Treatment of metastatic melanoma with electrochemotherapy

Journal of Surgical Oncology

Volumn 109, Issue 4, 2014, Pages 301-307

  Campana, Luca G ^a   Testori, Alessandro ^b   Mozzillo, Nicola ^c   Rossi, Carlo Riccardo ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

bleomycin; electrochemotherapy; locoregional therapies; melanoma; palliative therapy

Indexed keywords

ANIMALS; ELECTROCHEMOTHERAPY; HUMANS; MELANOMA; NEOPLASM METASTASIS;

EID: 84893967493     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23512     Document Type: Review

References (56)

1. Lookingbill DP, Spangler N, Helm KF:, Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients. J Am Acad Dermatol 1993; 29: 228-236.
2. Schwartz RA:, Cutaneous metastatic disease. J Am Acad Dermatol 1995; 33: 161-182.
3. Wong TK, Neumann E:, Electric field mediated gene transfer. Biochem Biophys Res Commun 1982; 107: 584-587.
4. Gehl J:, Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437-447.
5. Heller LC, Heller R:, Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 2010; 10: 312-317.
6. Mali B, Jarm T, Snoj M, et al.: Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. Eur J Surg Oncol 2013; 39: 4-16.
7. Gimbel MI, Delman KA, Zager JS:, Therapy for unresectable recurrent and in-transit extremity melanoma. Cancer Control 2008; 15: 225-232.
8. Orlowski S, Belehradek J Jr, Paoletti C, et al.: Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37: 4727-4733. et al.
9. Larkin JO, Collins CG, Aarons S, et al.: Electrochemotherapy: Aspects of preclinical development and early clinical experience. Ann Surg 2007; 245: 469-479.
10. Sadadcharam M, Soden DM, O'Sullivan GC:, Electrochemotherapy: An emerging cancer treatment. Int J Hyperthermia 2008; 24: 263-273.
11. Mir L:, Bases and rationale of the electrochemotherapy. Eur J Cancer Suppl 2006; 4: 38-44.
12. Sersa G, Cufer T, Paulin SM, et al.: Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treat Rev 2012; 38: 379-386.
13. Jarm T, Cemazar M, Miklavcic D, et al.: Antivascular effects of electrochemotherapy: Implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010; 10: 729-746.
14. Sersa G, Cemazar M, Parkins CS, et al.: Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 1999; 35: 672-677.
15. Cemazar M, Parkins C, Holder A, et al.: Electroporation of human microvascular endothelial cells: Evidence for an antivascular mechanism of electrochemotherapy. Br J Cancer 2001; 84: 565-570.
16. Sersa G, Jarm T, Kotnik T, et al.: Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 2008; 98: 388-398.
17. Mir LM, Roth C, Orlowski S, et al.: Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol 1995; 17: 30-38.
18. Sersa G, Cemazar M, Menart V, et al.: Antitumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. Cancer Lett 1997; 116: 85-92.
19. Mir L, Gehl J, Sersa G, et al.: Standard operating procedures of the lectrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the cliniporator-TM by means of invasive or noninvasive electrodes. Eur J Cancer Suppl 2006; 4: 14-25.
20. Sersa G, Stabuc B, Cemazar M, et al.: Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer 1998; 34: 1213-1218.
21. Campana LG, Mocellin S, Basso M, et al.: Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 2009; 16: 191-199.
22. Testori A, Tosti G, Martinoli C, et al.: Electrochemotherapy for cutaneous and subcutaneous tumor lesions: A novel therapeutic approach. Dermatol Ther 2010; 23: 651-661.
23. Sersa G:, The state-of-the-art of electrochemotherapy before the ESOPE study; advantages and clinical uses. EJC Suppl 2006; 4: 52-59.
24. Gaudy C, Richard MA, Folchetti G, et al.: Randomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanoma. J Cutan Med Surg 2006; 10: 115-121.
25. Staal LG, Gilbert R:, Generators and applicators: Equipment for electroporation. In:, Kee ST, Gehl J, Lee EW, editors. Clinical aspect of electroporation. New York Dordrecht Heildelberg London: Springer; 2011. pp. 45-65.
26. Miklavcic D, Corovic S, Pucihar G, et al.: Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. EJC 4 Suppl 2006; 45-51.
27. Corovic S, Lackovic I, Sustaric P, et al.: Modeling of electric field distribution in tissues during electroporation. Biomed Eng Online 2013; 12: 16.
28. Rudolf Z, Stabuc B, Cemazr M, et al.: Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol Oncol 1995; 29: 229-235.
29. Glass LF, Pepine ML, Fenske NA, et al.: Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996; 132: 1353-1357.
30. Heller R, Jaroszeski MJ, Reintgen DS, et al.: Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83: 148-157.
31. Mir LM, Glass LF, Sersa G, et al.: Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77: 2336-2342.
32. Sersa G, Stabuc B, Cemazar M, et al.: Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients. Clin Cancer Res 2000; 6: 863-867.
33. Sersa G, Cemazar M, Rudolf Z:, Electrochemotherapy: Advanteges and drawbacks in treatment of cancer patients. Cancer Ther 2003; 1: 133-142.
34. Heller R, Jaroszeski MJ, Glass LF, et al.: Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77: 964-971.
35. Kubota Y, Mir LM, Nakada T, et al.: Successful treatment of metastatic skin lesions with electrochemotherapy. J Urol 1998; 160: 1426.
36. Rols MP, Bachaud JM, Giraud P, et al.: Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res 2000; 10: 468-4674.
37. Sersa G, Stabuc B, Cemazar M, et al.: Electrochemotherapy with cisplatin: The systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res 2000; 10: 381-385.
38. Rodriguez-Cuevas S, Barroso-Bravo S, Manza-Estrada J, et al.: Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin. Arch Med Res 2001; 32: 273-276.
39. Byrne CM, Thompson JF, Johnston H, et al.: Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Res 2005; 15: 45-51.
40. Snoj M, Rudolf Z, Cemazar M, et al.: Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs 2005; 16: 345-348.
41. Gehl J, Geertsen PF:, Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000; 10: 585-589.
42. Marty M, Sersa G, Garbay JR, et al.: Electrochemotherapy-An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3-13.
43. Quaglino P, Mortera C, Osella-Abate S, et al.: Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008; 15: 2215-2222.
44. Campana LG, Valpione S, Mocellin S, et al.: Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg 2012; 99: 821-830.
45. Mozzillo N, Caracò C, Mori S, et al.: Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma. J Transl Med 2012; 10: 131.
46. Kis E, Oláh J, Ócsai H, et al.: Electrochemotherapy of cutaneous metastases of melanoma-A case series study and systematic review of the evidence. Dermatol Surg 2011; 37: 816-824.
47. Möller MG, Salwa S, Soden DM, et al.: Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma. Expert Rev Anticancer Ther 2009; 9: 1611-1630.
48. Testori A, Faries MB, Thompson JF, et al.: Local and intralesional therapy of in-transit melanoma metastases. J Surg Oncol 2011; 104: 391-396.
49. Byrne CM, Thompson JF:, Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert Rev Anticancer Ther 2006; 6: 671-678.
50. Miklavčič D, Serša G, Brecelj E, et al.: Electrochemotherapy: Technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 2012; 50: 1213-1225.
51. Sersa G, Miklavcic D, Cemazar M, et al.: Electrochemotherapy with CDDP on LPB sarcoma: Comparison of the antitumor effectiveness in immunocompetent and immunodeficient mice. Bioelectrochem Bioenerg 1997; 43: 279-283.
52. Orlowski S, An D, Belehradek J Jr, et al.: Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin-2-secreting cells in the murine Lewis lung tumor. Anticancer drugs 1998; 9: 551-556.
53. Roux S, Bernat C, Al-Sakere B, et al.: Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses. Cancer Immunol Immunother 2008; 57: 1291-1300.
54. Quaglino P, Osella-Abate S, Marenco F, et al.: FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy. Pigment Cell Melanoma Res 2011; 24: 734-736.
55. Gerlini G, Sestini S, Di Gennaro P, et al.: Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy. Clin Exp Metastasis 2013; 30: 37-45.
56. Gerlini G, Di Gennaro P, Borgognoni L:, Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation. Oncoimmunology 2012; 1: 1655-1657.